Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Miller

Showing results (201-210 of 236) with videos related to

Pageof 24
Sort By:
Arxiv|July 3, 2026
pVACtools v6: A comprehensive suite for neoantigen prediction, visualization, and therapy designMy H Hoang, Susanna Kiwala, Megan Richters, et al.
The New England Journal of Medicine|November 1, 2018
Immune Escape of Relapsed AML Cells after Allogeneic TransplantationMatthew J Christopher, Allegra A Petti, Michael P Rettig, et al.
Blood Cancer Discovery|June 16, 2022
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome ProgressionAndrew J Menssen, Ajay Khanna, Christopher A Miller, et al.
Blood|October 24, 2015
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemiaJane E Churpek, Khateriaa Pyrtel, Krishna-Latha Kanchi, et al.
Science Immunology|April 7, 2023
Computational prediction of MHC anchor locations guides neoantigen identification and prioritizationHuiming Xia, Joshua McMichael, Michelle Becker-Hapak, et al.
Leukemia|October 4, 2024
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment responseMeagan A Jacoby, Eric D Duncavage, Ajay Khanna, et al.
The New England Journal of Medicine|March 11, 2021
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid CancersEric J Duncavage, Molly C Schroeder, Michele O'Laughlin, et al.
The New England Journal of Medicine|September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.
Nature Communications|January 23, 2014
Integrated analysis of germline and somatic variants in ovarian cancerKrishna L Kanchi, Kimberly J Johnson, Charles Lu, et al.
Cell Systems|December 9, 2015
Optimizing cancer genome sequencing and analysisMalachi Griffith, Christopher A Miller, Obi L Griffith, et al.
Pageof 24

Showing results (201-210 of 236) with videos related to

Sort By:
Pageof 24
Arxiv|July 3, 2026
pVACtools v6: A comprehensive suite for neoantigen prediction, visualization, and therapy designMy H Hoang, Susanna Kiwala, Megan Richters, et al.
The New England Journal of Medicine|November 1, 2018
Immune Escape of Relapsed AML Cells after Allogeneic TransplantationMatthew J Christopher, Allegra A Petti, Michael P Rettig, et al.
Blood Cancer Discovery|June 16, 2022
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome ProgressionAndrew J Menssen, Ajay Khanna, Christopher A Miller, et al.
Blood|October 24, 2015
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemiaJane E Churpek, Khateriaa Pyrtel, Krishna-Latha Kanchi, et al.
Science Immunology|April 7, 2023
Computational prediction of MHC anchor locations guides neoantigen identification and prioritizationHuiming Xia, Joshua McMichael, Michelle Becker-Hapak, et al.
Leukemia|October 4, 2024
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment responseMeagan A Jacoby, Eric D Duncavage, Ajay Khanna, et al.
The New England Journal of Medicine|March 11, 2021
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid CancersEric J Duncavage, Molly C Schroeder, Michele O'Laughlin, et al.
The New England Journal of Medicine|September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.
Nature Communications|January 23, 2014
Integrated analysis of germline and somatic variants in ovarian cancerKrishna L Kanchi, Kimberly J Johnson, Charles Lu, et al.
Cell Systems|December 9, 2015
Optimizing cancer genome sequencing and analysisMalachi Griffith, Christopher A Miller, Obi L Griffith, et al.
Pageof 24